España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Christopher Carey
Why Some Think Cannabis Will Thrive Even As GDPs Plunge
8 Stocks To Sell Into The Market Rally
BofA Downgrades Cronos, Says 'There's Just Little For Investors To Work With'
8 Stocks To Sell Into The Market Rally
BofA Downgrades Cronos, Says 'There's Just Little For Investors To Work With'
BofA Digs Up The Dirt On Scotts Miracle-Gro
BofA On Organigram, Tilray, Aphria's Cash, Demand Trends
BofA Digs Up The Dirt On Scotts Miracle-Gro
BofA On Organigram, Tilray, Aphria's Cash, Demand Trends
Canopy Growth Analysts Back Closures, Layoffs: 'A Bold Move'
Why Cannabis Stocks Need To Go 'Beyond Flower'
Read More...
Christopher Carey Recent News
Canopy Growth Analysts Applaud Q3 Report, Stock Rallies: 'Revenue Momentum Has Returned'
Aurora Cannabis Analyst Says Company Needs 'Much Work On Costs'
7 Cannabis Stocks To Buy, Sell And Hold
BofA Says Canopy Growth Should Take Action To Right-Size Costs
Analyst Raises Price Objectives For Cannabis Stocks: 'Higher Multiples Raise The Bar For All'
Organigram Analysts Say Stock's Post-Earnings Rally 'Overdone,' Company Should Add Leverage
Aurora Cannabis Downgraded By Piper Sandler, BofA
Bank Of America Looks At Colorado Sales In Monthly Cannabis Tracker
Canopy Growth Is Prepared For 'Cannabis 2.0' In Canada, Analysts Say
'Worst Looks Over' For Canopy Growth, Bank Of America Says In Upgrade
Canopy Growth Analysts Lower Price Targets After Q2 Report
Canopy Growth Analysts Parse Q2 Print As Investors Retreat
BofA: Cronos Group Has Potential To Be Long-Term Cannabis Leader
Analyst: Canopy Growth Looks Greener Than It Did 6 Weeks Ago
Hexo Analysts React To Resignation Of Cannabis Company's CFO: 'What Don't We Know?'
Bank Of America Upgrades Scotts Miracle-Gro, High On Cannabis Prospects
Bank Of America Downgrades Canopy Growth, Projects 26% Revenue Miss
Aurora Investors Aren't Feeling The Buzz After Q4 Print: 2 Analyst Takes
Tobacco Stocks Rebound As Trump Says 'We Have To Do Something On Vaping'
Bank Of America: There's Still A Canadian Cannabis Bottleneck
Analyst: Cronos-Redwood Deal 'Just The Tip Of The Iceberg'
Bank Of America Downgrades Aurora Cannabis, Concerned About Cash Burn
A Technical Breakdown In Cannabis Stocks